When Christopher Columbus first sighted land in October 1492, he thought he had reached Japan. That’s how bad his map was.  In medicine, we rely increasingly on biomarkers (indicators of disease) to ”map” our health, disease risks, disease conditions, and responses to treatment. Some b...

Casey Jean Silvernale was diagnosed at age 11 with Crohn’s disease. Now, more than a dozen years later, she’s working as a clinical research coordinator in the Center for Neurointestinal Health at Massachusetts General Hospital and studying for her MCATS (the admissions test for medical...

Although the main purpose of IBD Innovate 2019 was to showcase new IBD products, the Crohn's & Colitis Foundation also wanted to make sure researchers and developers were up-to-date about current developments in data exchange research platforms. Having data exchange platforms openly...

The following are two patient stories that were recently presented at the Crohn's & Colitis Foundation's second annual IBD Innovate Conference. They demonstrate how patients are taking active roles in creating new products to help IBD patients. Crohn’s patient Slawa Madelska and Dr...

At the end of 2019, the Crohn’s & Colitis Foundation convened the second annual IBD Innovate, our unique showcase and networking event for innovators working in the inflammatory bowel disease (IBD) space.    By bringing together developers engaged in the creation of new and innovat...

Living with a chronic illness, like Crohn’s disease or ulcerative colitis, can affect not only your physical health but also your mental health and emotional well-being. In fact, the rate of anxiety and depression among IBD patients is two to three times higher than that of the general ...

Have you ever noticed that your quality of treatment in a hospital changes based on the time of day and/or the day of the week that you are there? It’s true; the care you receive during regular hours on a weekday can vary drastically from the weekend. This is often referred to as the we...

March is Women’s History Month. The Crohn’s & Colitis Foundation would like to take this opportunity to put the spotlight on some of the fearless women leaders committed to making a difference for IBD patients. For this edition, Cecile Norris, Senior Research Manager at the Foundati...

In recent years, it has been increasingly recognized that the microbes which inhabit the intestinal tract, termed microbiota, have a profound impact on IBD. These microbes are essential to human health, but can become a liability during inflammatory gut disorders. Targeting these microb...